Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.

Clinical trial NCT07489989 · RECRUITING

Trial details

NCT number: NCT07489989
Sponsor: Daihong Liu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Start date: 2025-05-15
Primary completion: 2027-05-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.